Jazz’s biliary tract cancer drug Ziihera and Lilly’s Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.

The bleak European approval potential for Soleno Therapeutics’ genetic obesity drug essentially forced the US drugmaker to sell itself for less than it was once

Flagship Pioneering, the life science investment firm that helped make medicines out of mRNA by launching Moderna, has similarly grand ambitions for DNA. On Tuesday,

Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus erythematosus.

UCB is teaming with the Myasthenia Gravis Foundation of America and Factor Meals to provide premade meals to 250 families affected by myasthenia gravis, a